Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 15: | Line 15: | ||
* Alimta - Generic: Pemetrexed | * Alimta - Generic: Pemetrexed | ||
* Folotyn - Generic: Pralatrexate | * Folotyn - Generic: Pralatrexate | ||
| - | * [[Methotrexate]] | + | * [[Methotrexate]] - Trade names: [[Trexall]], [[Rheumatrex]], [[Otrexup]] |
* Raltitrexed | * Raltitrexed | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitors===== | =====[[Epidermal Growth Factor Receptor]] Inhibitors===== | ||
Revision as of 06:59, 22 October 2023
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
Chemotherapy
Dihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitors
Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitors= |
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
